Drug Profile
Hyaluronic acid - Huons
Alternative Names: Humia; Humia-14002Latest Information Update: 22 Feb 2022
Price :
$50
*
At a glance
- Originator Huons
- Class Adjuvants; Antirheumatics; Eye disorder therapies; Glycosaminoglycans; Urologics
- Mechanism of Action Hyaluronic acid replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 22 Feb 2022 No development reported - Phase-III for Osteoarthritis in South Korea (Injection)
- 01 Apr 2018 Huons completes a phase III trial in Osteoarthritis in South Korea (Injection) (NCT02893098)
- 01 Aug 2016 Phase-III clinical trials in Osteoarthritis in South Korea (Injection) (NCT02893098)